MedAdvisor Statistics

Total Valuation

MedAdvisor has a market cap or net worth of AUD 165.39 million. The enterprise value is 162.42 million.

Market Cap	165.39M
Enterprise Value	162.42M

Important Dates

The last earnings date was Thursday, October 24, 2024.

Earnings Date	Oct 24, 2024
Ex-Dividend Date	n/a

Share Statistics

MedAdvisor has 551.31 million shares outstanding. The number of shares has increased by 9.57% in one year.

Current Share Class	n/a
Shares Outstanding	551.31M
Shares Change (YoY)	+9.57%
Shares Change (QoQ)	+0.46%
Owned by Insiders (%)	4.18%
Owned by Institutions (%)	16.93%
Float	319.93M

Valuation Ratios

The trailing PE ratio is 230.77 and the forward PE ratio is 150.00.

PE Ratio	230.77
Forward PE	150.00
PS Ratio	1.35
PB Ratio	3.20
P/TBV Ratio	n/a
P/FCF Ratio	32.29
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 33.52, with an EV/FCF ratio of 31.71.

EV / Earnings	205.04
EV / Sales	1.33
EV / EBITDA	33.52
EV / EBIT	58.23
EV / FCF	31.71

Financial Position

The company has a current ratio of 0.71, with a Debt / Equity ratio of 0.24.

Current Ratio	0.71
Quick Ratio	0.67
Debt / Equity	0.24
Debt / EBITDA	2.60
Debt / FCF	2.46
Interest Coverage	1.45

Financial Efficiency

Return on equity (ROE) is 1.58% and return on invested capital (ROIC) is 2.77%.

Return on Equity (ROE)	1.58%
Return on Assets (ROA)	1.79%
Return on Capital (ROIC)	2.77%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.25
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +71.43% in the last 52 weeks. The beta is 0.67, so MedAdvisor's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	+71.43%
50-Day Moving Average	0.34
200-Day Moving Average	0.38
Relative Strength Index (RSI)	50.43
Average Volume (20 Days)	3,048,125

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedAdvisor had revenue of AUD 122.11 million and earned 792,133 in profits. Earnings per share was 0.00.

Revenue	122.11M
Gross Profit	27.92M
Operating Income	2.79M
Pretax Income	923,583
Net Income	792,133
EBITDA	4.18M
EBIT	2.79M
Earnings Per Share (EPS)	0.00

Full Income Statement

Balance Sheet

The company has 15.58 million in cash and 12.61 million in debt, giving a net cash position of 2.97 million or 0.01 per share.

Cash & Cash Equivalents	15.58M
Total Debt	12.61M
Net Cash	2.97M
Net Cash Per Share	0.01
Equity (Book Value)	51.58M
Book Value Per Share	0.09
Working Capital	-13.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.19 million and capital expenditures -65,279, giving a free cash flow of 5.12 million.

Operating Cash Flow	5.19M
Capital Expenditures	-65,279
Free Cash Flow	5.12M
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 22.86%, with operating and profit margins of 2.28% and 0.65%.

Gross Margin	22.86%
Operating Margin	2.28%
Pretax Margin	0.76%
Profit Margin	0.65%
EBITDA Margin	3.42%
EBIT Margin	2.28%
FCF Margin	4.20%

Dividends & Yields

MedAdvisor does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.57%
Shareholder Yield	-9.57%
Earnings Yield	0.43%
FCF Yield	3.10%

Stock Splits

The last stock split was on November 20, 2019. It was a reverse split with a ratio of 0.1428571429.

Last Split Date	Nov 20, 2019
Split Type	Reverse
Split Ratio	0.1428571429

Scores

MedAdvisor has an Altman Z-Score of 2.01. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.01
Piotroski F-Score	n/a